Poets & Quants names HOPO Therapeutics a 2022 Most Disruptive MBA Startup

HOPO Therapeutics has been named of 2022’s Most Disruptive MBA Startups by Poets & Quants. Hannah Weber, VP of Strategy & Business Development, sat down with Jeff Schmitt to discuss our work.

“Lead poisoning affects over 1 billion people, comparable to Malaria or HIV, but there has been no innovation in treatment in decades. With 99% of all patients left without any available treatment, most living in low- and middle-income countries, we feel driven to provide a safe and affordable solution.

I can very clearly envision a world where HOPO has built a new model for access to medicines. We see ourselves as a global health company, and are aiming to create novel, affordable medicines that will finally make heavy metal exposure treatable. As metal pollution increases, we want to create a world where living in older housing, or next to an airfield, or near a recycling plant does not predetermine poor health or intelligence outcomes. Our long-term goal is for HOPO to be at the intersection of breakthrough therapies and equitable, accessible healthcare.”